Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-035889
Filing Date
2010-04-19
Accepted
2010-04-19 16:06:31
Documents
1
Period of Report
2010-06-08
Effectiveness Date
2010-04-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A c99077def14a.htm DEF 14A 491092
  Complete submission text file 0000950123-10-035889.txt   492635
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 10757322
SIC: 2835 In Vitro & In Vivo Diagnostic Substances